Naproxendrug info
naproxen 25 MG/ML Oral Suspension
What it is used for
1 INDICATIONS & USAGE Naproxen oral suspension is indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis tendonitis bursitis acute gout the management of: pain. primary dysmenorrhea Naproxen oral suspension is a non-steroidal anti-inflammatory drug indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis tendonitis bursitis acute gout the management of: pain. primary dysmenorrhea
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective March 25, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Naproxen oral suspension, USP is available as a light-orange colored, pineapple flavored suspension containing 125 mg/5 mL of naproxen for oral administration. Naproxen is a propionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs. The chemical name is (S)-6-methoxy-α-methyl-2-naphthaleneacetic acid. The molecular weight is 230.26. Its molecular formula is C 14 H 14 O 3, and it has the following chemical structure. Naproxen is an odorless, white to off-white crystalline substance. It is practically insoluble in water, soluble in ethanol and methanol. The octanol/water partition coefficient of naproxen at pH 7.4 is 1.6 to 1.8. The inactive ingredients in naproxen oral suspension are: sucrose, sorbitol solution, sodium chloride, methylparaben, fumaric acid, FD&C Yellow No. 6, pineapple flavor, propylene glycol, sodium carboxymethyl cellulose, polysorbate 80, colloidal silicon dioxide, hydroxyethyl cellulose and purified water. structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective March 25, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance